Cardlytics, Inc.
US ˙ NasdaqGM ˙ US14161W1053

SecurityCDLX / Cardlytics, Inc.
InstitutionUs Bancorp \de\
Latest Disclosed Ownership1,591 shares
Latest Disclosed Value $ 1,671
Us Bancorp \de\ reports 40.90% decrease in ownership of CDLX / Cardlytics, Inc.

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 1,591 shares of Cardlytics, Inc. (US:CDLX) valued at $1,671 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 2,692 shares of Cardlytics, Inc.. This represents a change in shares of -40.90% during the quarter. The current value of the position is $971 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CARDLYTICS COM 14161W105 1,591 -1,101 -40.90 2 -66.67 0.0000
2026-01-30 2025-12-31 13F CARDLYTICS COM 14161W105 2,692 -711 -20.89 3 -62.50 0.0000
2025-11-12 2025-09-30 13F CARDLYTICS COM 14161W105 3,403 0 0.00 8 60.00 0.0000
2025-07-24 2025-06-30 13F CARDLYTICS COM 14161W105 3,403 711 26.41 6 25.00 0.0000
2025-05-08 2025-03-31 13F CARDLYTICS COM 14161W105 2,692 -4,212 -61.01 5 -84.00 0.0000
2025-02-05 2024-12-31 13F CARDLYTICS COM 14161W105 6,904 1,692 32.46 26 56.25 0.0000
2024-10-28 2024-09-30 13F CARDLYTICS COM 14161W105 5,212 5,212 17 0.0000
2024-02-09 2023-12-31 13F CARDLYTICS COM 14161W105 0 -88 -100.00 0 -100.00
2023-11-03 2023-09-30 13F CARDLYTICS COM 14161W105 88 88 1 0.0000
2023-02-13 2022-12-31 13F CARDLYTICS COMMON STOCK 14161W105 0 -323 -100.00 0 -100.00
2022-10-27 2022-09-30 13F CARDLYTICS COMMON STOCK 14161W105 323 -76 -19.05 3 -66.67 0.0000
2022-08-01 2022-06-30 13F CARDLYTICS COMMON STOCK 14161W105 399 363 1,008.33 9 350.00 0.0000
2022-05-11 2022-03-31 13F CARDLYTICS COMMON STOCK 14161W105 36 -27 -42.86 2 -50.00 0.0000
2022-02-11 2021-12-31 13F CARDLYTICS COMMON STOCK 14161W105 63 -211 -77.01 4 -82.61 0.0000
2021-11-10 2021-09-30 13F CARDLYTICS COMMON STOCK 14161W105 274 32 13.22 23 -25.81 0.0000
2021-08-05 2021-06-30 13F CARDLYTICS COMMON STOCK 14161W105 242 172 245.71 31 287.50 0.0001
2021-04-28 2021-03-31 13F CARDLYTICS COMMON STOCK 14161W105 70 -19 -21.35 8 -38.46 0.0000
2021-02-04 2020-12-31 13F CARDLYTICS COMMON STOCK 14161W105 89 5 5.95 13 116.67 0.0000
2020-11-10 2020-09-30 13F CARDLYTICS COMMON STOCK 14161W105 84 69 460.00 6 500.00 0.0000
2020-08-07 2020-06-30 13F CARDLYTICS COMMON STOCK 14161W105 15 15 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.